Watson-Marlow Fluid Technology Solutions showcases recently launched WMArchitect™ single-use solutions along with a range of pumps and hoses at CPHI Milan 2024

Watson-Marlow Fluid Technology Solutions (WMFTS) will display a range of peristaltic pumps and associated fluid path technologies for the life sciences industry during CPHI Milan 2024 at Fiera Milano on 8th – 10th October.

MATTER Selected to Lead the Digital Health Hub in the Next Generation of the BARDA Accelerator Network

The Biomedical Advanced Research and Development Authority (BARDA) has selected MATTER to lead the new Digital Health Hub as part of the BARDA Accelerator Network. The hub, called Paratus, will support the development of next-gen digital health technologies to address health security threats.

Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen’s Lawsuit

Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology represents a significant advancement in nucleic acid purification.

CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence

Phreesia, the National Association For Continence (NAFC), Health.Equity.Outcomes. and Christina Escobar, MD, at New York University, are proud to announce that the U.S. Centers for Disease Control and Prevention (CDC) has awarded a grant for a joint project focused on combating the public health challenge of urinary incontinence in women.

Sapio Sciences Partner Program Welcomes Astrix

Sapio Sciences, the science-aware™ lab informatics platform, today announced that Astrix, the market leader in creating and delivering innovative strategies, solutions, and people to the life science community, has joined the Sapio Sciences Partner Program, providing consulting and implementation services to life science and biotech customers.

eClinical Solutions Announces Growth Investment by GI Partners to Further Its Mission of Helping Bring Treatments to Patients Faster

eClinical Solutions LLC, a global provider of digital clinical software and services, today announced that GI Partners, a private investment firm, has made a majority investment in the company to advance the future of digital trials via continued enhancements to its leading AI-powered data products and biometrics services.

Global Cyber Security Expert, NCC Group Expands Digital Identity Services Amidst Growing Customer Demand

NCC Group has launched a new suite of digital identity services to help organizations manage and safeguard access to their digital assets, while optimizing operations and enhancing security.

Sunrise Labs, Inc. Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network

Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform

Cellares and Sony have announced a collaboration to integrate Sony’s flow cytometry-based sorting technology into Cellares' automated Cell Shuttle platform for cell therapy manufacturing. This integration will enhance automation, scalability, and real-time monitoring, improving the efficiency of sorting-dependent therapies like Treg and HSC. It aims to streamline the manufacturing process and reduce costs.

Opentrons introduces Flex Prep: A no-code robot offering the simplicity of a pipette with the versatility of a liquid handler

Opentrons introduces Flex Prep, a no-code robot combining the simplicity of a pipette with the versatility of a liquid handler. Its intuitive touchscreen allows scientists to program pipetting tasks in under a minute. Flex Prep enhances lab automation, offering affordable and versatile capabilities for both basic and complex protocols, empowering researchers to automate tasks without prior robotics experience.

GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research

GenNext Technologies has announced a pioneering collaboration with Agilent, that promises to transform structural biology research for biopharmaceutical companies.

Breakthrough towards protein sequencing using Oxford Nanopore holds promise for disease research and drug development

In a research collaboration with Oxford Nanopore Technologies, scientists from the University of Washington have unveiled a groundbreaking ‘proof-of-concept’ method for reading single protein molecules

Cleveland Diagnostics’ Prostate Cancer Awareness Campaign ‘A PSA on PSA’ Returns This September

National Initiative to Increase Education & Awareness; Raise Funds for ZERO Prostate Cancer with Donation Made for Every Patient Discussion Guide Downloaded at PSAonPSA.com

PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the launch of MET Predict† on the AISightⓇ† Image management system (IMS). MET Predict is an AI-powered algorithm designed to help pathologists identify non-small cell lung cancer (NSCLC) tumors that may be more likely to have MET exon 14 skipping (METex14) or MET amplification, directly from an H&E whole slide image.

PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth

PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth Miami, FL – 10th September 2024, PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology platform and services for the Life Science industry.

Verisense Health Introduces an iOS App for its Smart Watch

The Verisense Smart Watch, Which Collects Digital Health Data During Clinical Trials, is Now Compatible with Both Apple and Android Smartphones.

Quotient Sciences and Vasa Therapeutics Announce Dosing of First Subjects with VS-041, a Novel Heart Failure Treatment

Envision Pharma Group launches EnvisionOne Insights: A unified data and analytics solution for medical affairs

One of the world’s leading technology solutions companies Envision Pharma Group has launched “EnvisionOne Insights” an innovative medical technology solution for the power of big dat

APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology

Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions with Launch of New Archer™ HRD Technology for Cancer Research